CoreAge Rx Addresses Stubborn Hyperpigmentation with Localized 'Spot On' Compound
Rather than applying broad facial creams, consumers can now utilize a targeted blend of hydroquinone and kojic acid to treat specific areas of discoloration.
Wichita Falls, TX, United States, 6th Aug 2026 - Managing sun damage and post-inflammatory hyperpigmentation frequently leaves consumers frustrated when standard, full-face brightening serums fail to produce results. Because dark spots stem from localized melanin overproduction, resolving them requires a concentrated approach rather than generalized daily moisturizers. To address this specific issue, digital health platform CoreAge Rx has introduced Spot On, a prescription topical formulated exclusively for precise application on stubborn areas of discoloration.
The compound manages uneven skin tone through a combination of three active ingredients. Hydroquinone serves as the primary depigmenting agent, acting directly to lighten hyperpigmented patches. Kojic acid is included to interrupt the production of new melanin, while niacinamide works to calm localized redness and maintain the skin's moisture barrier during treatment.
Medical providers emphasize that Spot On is not for general facial application. Patients must apply the cream strictly to the dark spots. Due to the high concentration of the active ingredients, physicians typically direct patients to use the treatment for defined intervals rather than indefinitely. Providers also require the daily use of broad-spectrum sunscreen and active sun avoidance to prevent the discoloration from recurring during and after the regimen.
Individuals can access the compound via the CoreAge Rx telehealth portal. Following a secure online health questionnaire, a physician reviews the intake to determine if the topical is medically appropriate. When authorized, a compounding pharmacy prepares the custom prescription and mails it to the patient. The service is available for $54.99 per month, covering the medical consultation, medication, and delivery without requiring mandatory subscriptions.
For additional reading on the mechanisms of treating skin discoloration, view the featured article: A Modern Approach to Hyperpigmentation: How CoreAge Rx Is Reimagining Targeted Skincare.
Learn more at https://www.coreagerx.com/product/spot-on
About CoreAge Rx
CoreAge Rx operates as a digital health platform connecting patients with physicians for virtual medical assessments. The organization coordinates the direct delivery of prescription treatments and health solutions to the consumer. By facilitating virtual care across weight management, longevity, and dermatology, CoreAge Rx delivers practical healthcare options designed for daily life.
For more information, visit coreagerx.com
Media Contact
Organization: CoreAge Rx
Contact Person: Ella Jones
Website: https://www.coreagerx.com/
Email: Send Email
Contact Number: +19404004927
City: Wichita Falls
State: TX
Country:United States
Release id:47923
The post CoreAge Rx Addresses Stubborn Hyperpigmentation with Localized 'Spot On' Compound appeared first on King Newswire. This content is provided by a third-party source.. King Newswire is a press release distribution agency. We do not accept any responsibility or liability for the accuracy, content, images, videos, licences, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section above.
Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.
